Search and media site Yahoo! Inc (NASDAQ:YHOO)  gains modestly Wednesday as its partner, China’s Alibaba Group, rolls out a beta version of a U.S. e-commerce site, Reuters reported. YHOO holds a significant stake in Alibaba, valued recently at about $26 billion.  Yahoo! Inc. (NASDAQ:YHOO) stock performance was 0.55% in last session and finished the day at $36.51. Traded volume was 13.32million shares in the last session and the average volume of the stock remained 22.01million shares. The beta of the stock remained 1.01. Yahoo! Inc. (NASDAQ:YHOO) insider ownership is 0.50%.

Geron Corporation (NASDAQ:GERN) on May 9 announced that it has set May 28, 2014 as the record date for the distribution to Geron stockholders of the Series A Common Stock from Asterias Biotherapeutics, Inc. (“Asterias”) that Geron received in the previously announced transaction to divest Geron`s human embryonic stem cell assets, which closed on October 1, 2013. Geron Corporation (NASDAQ:GERN) rose 10.64 percent to $2.60 Wednesday on volume of 13.52million shares. The intra-day range of the stock was $2.25 to $2.77. Geron Corporation (NASDAQ:GERN) has a market capitalization of $408.06million.

American Airlines Group Inc (NASDAQ:AAL) will take delivery of its first Boeing 787, known as the Dreamliner, in November. Passenger flights begin early next year. In the next few months, American pilots will sit in the same simulator and learn the nuances of the controls before they can fly the real plane. In a statement to The Associated Press, the company said it was “in constant dialogue with Boeing and we look forward to adding the 787 to our fleet.”American Airlines Group Inc (NASDAQ:AAL)’s stock on June 11, 2014 reported a decrease of -3.14% to the closing price of $42.29. Its fifty two weeks range is $23.45 -$44.43. The total market capitalization recorded $30.46billion. The overall volume in the last trading session was 13.19million shares. In its share capital, AAL has 720.20million outstanding shares.

Galena Biopharma, Inc. (NASDAQ:GALE), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. On Wednesday, shares of Galena Biopharma Inc (NASDAQ:GALE) advanced 3.84% to close the day at $3.25. Company return on investment (ROI) is -225.80% and its monthly performance is recorded as 36.55%.

Micron Technology Inc. (NASDAQ:MU) shares shot up 6.2% during mid-day trading on Wednesday after Bank of America upgraded the stock from an underperform rating to a buy rating, AnalystRatingsNetwork reports. Bank of America now has a $40.00 price target on the stock, up from their previous price target of $22.00. Micron Technology traded as high as $31.40 and last traded at $31.34, with a volume of 33,334,123 shares changing hands. Micron Technology, Inc. (NASDAQ:MU) stock performance was 5.02% in last session and finished the day at $30.99. Traded volume was 55.47million shares in the last session and the average volume of the stock remained 28.68million shares. The beta of the stock remained 1.81. Micron Technology, Inc. (NASDAQ:MU) insider ownership is 0.60%.